Genedrive (LSE:GDR) Land And Improvements : £0.00 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Genedrive Land And Improvements?

Genedrive's land and improvements for the quarter that ended in Dec. 2023 was £0.00 Mil.

Genedrive Land And Improvements Historical Data

The historical data trend for Genedrive's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genedrive Land And Improvements Chart

Genedrive Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Land And Improvements

Get a 7-Day Free Trial

Genedrive Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Land And Improvements	Get a 7-Day Free Trial															-	-	-	-	-

Genedrive Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Genedrive (LSE:GDR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genedrive PLC (LSE:GDR) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

D6M:Germany D6M:Germany

Address

48 Grafton Street, The Incubator Building, Manchester, GBR, M13 9XX

Website

http://www.genedriveplc.com

Genedrive PLC is a holding company engaged in the molecular diagnostics business. It operates in one operating segment named Diagnostics which is engaged in the Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and use in patient stratification (genotyping), pathogen detection, and other indications. Geographically the majority of the revenue is derived from the United Kingdom.

Genedrive (LSE:GDR) Headlines

No Headlines